More importantly, in both the constructed liver-specific FABP5 knockout spontaneous liver cancer mouse model and the HCC xenograft tumor model, FABP5 deletion effectively inhibited tumor growth, reduced M2-type TAM infiltration and lipid accumulation, and promoted the recruitment of anti-tumor immune cells such as CD8+ T cells. This evidence concerns the gene CD8A and liver cancer.